Nuclear Imaging and Echocardiographic Findings in Hypertrophic Cardiomyopathy with and without ATTR-CM
In this real-world study, a high level of concordance was seen in cardiac uptake grading on planar versus SPECT imaging, with discordant findings only observed with [<sup>99m</sup>Tc]Tc-PYP. The findings support the use of these imaging tools to facilitate ATTR-CM screening in clinical practice. Further studies should investigate differences across tracers used in ATTR-CM screening. NCT03842163.
Authors
- Roberto Barriales‐Villa (ORCID: https://orcid.org/0000-0002-6721-3487)
- Perry Elliott (ORCID: https://orcid.org/0000-0003-3383-3984)
- Carmen Munteanu
- Emmanuel Itti (ORCID: https://orcid.org/0000-0003-1578-4058)
- Pablo García‐Pavía (ORCID: https://orcid.org/0000-0002-5470-2257)
- Denis Keohane
- Francesco Cappelli (ORCID: https://orcid.org/0000-0002-1622-0732)
- Pablo Mallaina
- Nicolas Piriou (ORCID: https://orcid.org/0000-0002-6677-6552)
- Catherine Bahus
- F. Moral
- Thibaud Damy
Institutions
- Inserm (FR)
- Pfizer (United States) (US)
- Université Paris-Est Créteil (FR)
- Universidad Francisco de Vitoria (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Complexo Hospitalario Universitario A Coruña (ES)
- Institut du Thorax (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- University College London (GB)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1002/ehf2.15440
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer